Cargando…
High expression of VCAN is an independent predictor of poor prognosis in gastric cancer
OBJECTIVE: Versican (VCAN) has been reported as a potential biomarker in some cancers. However, its role in gastric cancer (GC) is poorly understood. METHODS: Associations between clinical variables and VCAN were assessed. The diagnostic value of VCAN expression in GC patients was determined through...
Autores principales: | Li, Wenfei, Han, Fang, Fu, Min, Wang, Zhanqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254169/ https://www.ncbi.nlm.nih.gov/pubmed/31939331 http://dx.doi.org/10.1177/0300060519891271 |
Ejemplares similares
-
Joint effect of THBS2 and VCAN accelerating the poor prognosis of gastric cancer
por: Wang, Long, et al.
Publicado: (2023) -
Low body mass index is an independent predictor of poor long-term prognosis among patients with resectable gastric cancer
por: Ma, Shuai, et al.
Publicado: (2021) -
Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancer
por: Huang, Xiao‐yan, et al.
Publicado: (2021) -
Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms
por: Han, Deng, et al.
Publicado: (2021) -
Sema3C promotes hepatic metastasis and predicts poor prognosis in gastric adenocarcinoma
por: Li, Maoran, et al.
Publicado: (2021)